Skip to main content
. 2021 Dec 23;7(4):415–421. doi: 10.5114/ceh.2021.111003

Table 3.

Effects of gender, diabetes mellitus (DM), thyroid disease and gluten-free diet (GFD) adherence on liver enzymes

Liver enzymes
N ALT-0
mean ±SD
ALT-6
mean ±SD
ALT-12
mean ±SD
AST-0
mean ±SD
AST-6
mean ±SD
AST-12
mean ±SD
GGT-0
mean ±SD
GGT-6
mean ±SD
GGT-12
mean ±SD
Gender
Male 30 42.7 ±34 30.1 ±11 30 ±10.8 41.1 ±39 31.6 ±14 30.6 ±14 13.9 ±13 20.9 ±36.5 13.1 ±9.4
Female 22 34.8 ±20 27.7 ±11.6 31.3 ±14.5 30.6 ±32 28.3 ±15 28.6 ±14 17.7 ±21.8 13.3 ±12.3 19.5 ±26.9
*p value 0.46 0.24 0.85
DM
Yes 21 45.5 ±34 31.8 ±10.9 33.4 ±12.6 38.6 ±37.6 32.9 ±17.8 32.9 ±18.4 17.9 ±19.9 16.4 ±12.8 19.6 ±27
No 31 35.3 ±24.9 27.2 ±11.2 28.6 ±12 35.4 ±28.4 28.4 ±11.8 27.6 ±10 13.8 ±15.2 18.5 ±36 13.3 ±10
*p value 0.11 0.33 0.56
Thyroid disease
Yes 14 46.4 ±33.8 31.9 ±10.6 33.9 ±12 35 ±40.8 26.6 ±13.5 26.6 ±13.7 17.4 ±21.6 20.3 ±20.5 22.3 ±32.3
No 38 36.8 ±27.3 28 ±11.4 29 ±12.5 37.2 ±28.9 31.6 ±14.9 30.8 ±14.3 14.8 ±15.6 16.7 ±31.6 13.5 ±10.3
*p value 0.18 0.45 0.33
GFD adherence
Good 39 42.8 ±32.3 29.3 ±11.9 31.8 ±12.9 40.2 ±25.8 29.8 ±11.9 29.6 ±12.7 17.9 ±19.2 20.1 ±32.9 17.2 ±21.5
Poor 13 29.2 ±10.9 28.5 ±9.4 26.9 ±10.3 26.1 ±13 31.3 ±21 29.9 ±18.4 8.4 ±4.2 10.5 ±6.4 11.7 ±6.4
*p value 0.17 0.42 0.12

ALT-0 – alanine transaminase at baseline, ALT-6 – alanine transaminase at 6 months after GFD, ALT-12 – alanine transaminase 12 months after GFD, AST-0 – aspartate transaminase at baseline, AST-6 – aspartate transaminase 6 months after GFD, AST-12 – aspartate transaminase 12 months after GFD, GGT-0 – γ-glutamyl transferase at baseline, GGT-6 – γ-glutamyl transferase at 6 months after GFD, GGT-12 – γ-glutamyl transferase at 12 months after GFD

* mixed-design ANOVA